We’ve recently updated our valuation analysis.

IDEXX Laboratories Valuation

Is IDXX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IDXX?

Other financial metrics that can be useful for relative valuation.

IDXX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue9.2x
Enterprise Value/EBITDA31.8x
PEG Ratio3.5x

Price to Earnings Ratio vs Peers

How does IDXX's PE Ratio compare to its peers?

IDXX PE Ratio vs Peers
The above table shows the PE ratio for IDXX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average91.6x
BAX Baxter International
28.7x19.1%US$29.1b
RMD ResMed
43.5x12.0%US$33.9b
DXCM DexCom
212.8x27.5%US$35.8b
ZBH Zimmer Biomet Holdings
81.2x22.1%US$23.6b
IDXX IDEXX Laboratories
43.9x12.5%US$29.1b

Price-To-Earnings vs Peers: IDXX is good value based on its Price-To-Earnings Ratio (43.9x) compared to the peer average (91.6x).


Price to Earnings Ratio vs Industry

How does IDXX's PE Ratio compare vs other companies in the US Medical Equipment Industry?

Price-To-Earnings vs Industry: IDXX is expensive based on its Price-To-Earnings Ratio (43.9x) compared to the US Medical Equipment industry average (33.6x)


Price to Earnings Ratio vs Fair Ratio

What is IDXX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IDXX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio43.9x
Fair PE Ratio36.4x

Price-To-Earnings vs Fair Ratio: IDXX is expensive based on its Price-To-Earnings Ratio (43.9x) compared to the estimated Fair Price-To-Earnings Ratio (36.4x).


Share Price vs Fair Value

What is the Fair Price of IDXX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IDXX ($350.12) is trading above our estimate of fair value ($278.4)

Significantly Below Fair Value: IDXX is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies